Nine of our 15 tumors (60%) showed CCNE1 copy number gains while data from TCGA (509 high grade serous ovarian carcinomas) presented CCNE1 gains in 32.4% or focal amplification in 20.8% [3]. The gene discussed is CCNE1; the disease is ovarian serous carcinoma.